US 10111953
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
granted A61KA61K2039/505A61K31/40
Quick answer
US patent 10111953 (Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K31/40, A61K39/3955, A61P